Dr. Martens plc (LON:DOCS)
London · Delayed Price · Currency is GBP · Price in GBX 86.20
+2.40 (2.86%)
Aug 11, 2026, 4:47 PM GMT
Dr. Martens Balance Sheet
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 180.3 | 155.9 | 111.1 | 157.5 | 228 |
Cash & Short-Term Investments | 180.3 | 155.9 | 111.1 | 157.5 | 228 |
Cash Growth | 15.65% | 40.32% | -29.46% | -30.92% | 100.70% |
Accounts Receivable | 70.7 | 62.4 | 68.8 | 93 | 85.6 |
Inventory | 160.8 | 187.4 | 254.6 | 257.8 | 123 |
Other Current Assets | 5.3 | 5.2 | 2.7 | 0.5 | 7 |
Total Current Assets | 417.1 | 410.9 | 437.2 | 508.8 | 443.6 |
Net Property, Plant & Equipment | 174.8 | 192.8 | 232.9 | 205.4 | 143.8 |
Other Intangible Assets | 270.4 | 274 | 270 | 265.6 | 262.1 |
Long-Term Investments | 1 | 1 | 1 | 1 | - |
Other Long-Term Assets | 14 | 11.1 | 11.3 | 11.8 | 9.6 |
Total Assets | 877.3 | 889.8 | 952.4 | 992.6 | 859.1 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 112.3 | 108.9 | 92.2 | 127.7 | 133.9 |
Accrued Expenses | - | - | - | - | 0.8 |
Current Portion of Long-Term Debt | 2.1 | 2.4 | 8.4 | 6 | - |
Current Portion of Leases | 44.1 | 45.9 | 47 | 28.1 | 19.8 |
Other Current Liabilities | 1.4 | 1.4 | 5.9 | 2.7 | 0.5 |
Total Current Liabilities | 159.9 | 158.6 | 153.5 | 164.5 | 155 |
Long-Term Debt | 247.6 | 246.3 | 286.3 | 293.4 | 280.9 |
Long-Term Leases | 99.7 | 109.5 | 135.3 | 124.3 | 93.1 |
Other Long-Term Liabilities | 8.6 | 9 | 9.1 | 6.2 | 1.9 |
Total Long-Term Liabilities | 355.9 | 364.8 | 430.7 | 423.9 | 375.9 |
Total Liabilities | 515.8 | 523.4 | 584.2 | 588.4 | 530.9 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 9.7 | 9.6 | 9.6 | 10 | 10 |
Treasury Stock | -6.7 | - | - | - | - |
Additional Paid-in Capital | -1,400 | -1,400 | -1,400 | -1,400 | -1,400 |
Accumulated Other Comprehensive Income | 1.6 | 7.3 | 10.6 | 12 | 6.9 |
Retained Earnings | 1,757 | 1,749 | 1,748 | 1,782 | 1,711 |
Shareholders' Equity | 361.5 | 366.4 | 368.2 | 404.2 | 328.2 |
Total Liabilities & Equity | 877.3 | 889.8 | 952.4 | 992.6 | 859.1 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Mar '25 Mar 30, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 393.5 | 404.1 | 477 | 451.8 | 393.8 |
Net Cash (Debt) | -213.2 | -248.2 | -365.9 | -294.3 | -165.8 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.22 | -0.26 | -0.37 | -0.29 | -0.17 |
Book Value | 361.5 | 366.4 | 368.2 | 404.2 | 328.2 |
Book Value Per Share | 0.37 | 0.38 | 0.37 | 0.40 | 0.33 |
Tangible Book Value | 91.1 | 92.4 | 98.2 | 138.6 | 66.1 |
Tangible Book Value Per Share | 0.09 | 0.09 | 0.10 | 0.14 | 0.07 |